Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mesothelioma × Data Collection × Thoracic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Small Cell Lung Carcinoma 1 Non-small Cell Lung Cancer Metastatic 1 Mesothelioma 1

Interventions

Pemetrexed 35 Cisplatin 30 pembrolizumab 19 Nivolumab 15 Carboplatin 15 Ipilimumab 11 Gemcitabine 9 Cyclophosphamide 7 durvalumab 6 fludarabine 5 Bevacizumab 5 Radiotherapy, Intensity-Modulated 4 Dexamethasone 4 tremelimumab 3 tazemetostat 3 olaparib 3 niraparib 3 anetumab ravtansine 3 Vinorelbine 3 Paclitaxel 3 LMB-100 3 Imatinib Mesylate 3 Fluorouracil 3 Cerebral Decortication 3 Blood Specimen Collection 3 sargramostim 2 fludarabine phosphate 2 defactinib 2 budigalimab 2 belinostat 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05308966 2025-10-06

MESO-IMMUNE

Groupe Francais De Pneumo-Cancerologie

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡